Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery
Evaluation the Treatment Outcome of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery.
Hepatocellular Carcinoma|Recurrence
DRUG: Aspirin|DRUG: Lamivudine
recurrence free survival, 36 months
overall survival, 36 months|adverse events, 36 months
The investigators conduct this clinical trial to evaluate the treatment outcome of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery.The primary outcome is overall survival and objective response rate.